Sennazon is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Bayshore Pharmaceuticals Llc [fl]. The primary component is Sennosides A And B.
| Product ID | 76518-100_28931b86-a3a1-42b5-a2df-45be00c37de3 |
| NDC | 76518-100 |
| Product Type | Human Otc Drug |
| Proprietary Name | Sennazon |
| Generic Name | Sennosides A And B |
| Dosage Form | Syrup |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-05-01 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Bayshore Pharmaceuticals LLC [FL] |
| Substance Name | SENNOSIDES A AND B |
| Active Ingredient Strength | 9 mg/5mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2012-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2012-05-01 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| SENNOSIDES A AND B | 8.8 mg/5mL |
| SPL SET ID: | 5d3106d5-ada2-4c98-8c99-f88df4849a56 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 76518-100 | Sennazon | Sennosides A and B |
| 42982-4441 | Bekunis Natures Gentle Stimulant Laxative | SENNOSIDES A AND B |
| 0536-1000 | Senexon | Sennosides A and B |
| 17856-1000 | Senexon | Sennosides A and B |
| 0904-6289 | Senna | Sennosides A and B |
| 17856-1107 | SENNA | SENNOSIDES A AND B |
| 17856-6289 | Senna | Sennosides A and B |
| 24451-289 | Senna | SENNOSIDES A AND B |
| 53807-556 | Senna | Sennosides A and B |
| 54162-007 | SENNA | SENNOSIDES A AND B |
| 68151-0648 | Senna | Sennosides A and B |
| 70166-636 | SENNA | SENNOSIDES A AND B |
| 66424-562 | SENNA Syrup | Sennosides A and B |
| 55700-128 | Senna-Lax | SENNOSIDES A AND B |
| 63629-3207 | Senna-Lax | SENNOSIDES A AND B |